Private company

Nippon Shinyaku

Logo: nippon-shinyaku.co.jp4

Japanese pharmaceutical company

Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that markets prescription drugs and functional foods.3 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

Sep 29, 1919Founded1
日本新薬 本社外観
Photo: Shinyakunippon, CC BY-SA 4.0, via Wikimedia Commons5

Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that markets prescription drugs and functional foods.3

Corporate structure

Nippon Shinyaku sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Timeline

  1. Sep 29, 1919Founded Founded1

Calendar

Drug trials and FDA: coming up

  1. Dec 2026Phase 2 trial readout expected Phase 2 trial of NS-229 in Eosinophilic Granulomatosis With Polyangiitis, run by NS Pharma, Inc.: primary completion expected Dec 2026 (ClinicalTrials.gov NCT06046222).6
  2. Feb 26, 2027Phase 2 trial readout expected Phase 2 trial of NS-089/NCNP-02 in Duchenne Muscular Dystrophy, run by NS Pharma, Inc.: primary completion expected Feb 26, 2027 (ClinicalTrials.gov NCT05996003).7
  3. Apr 30, 2027Phase 2 trial readout expected Phase 2 trial of NS-089/NCNP-02 in Duchenne Muscular Dystrophy (DMD): primary completion expected Apr 30, 2027 (ClinicalTrials.gov NCT05135663).8

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Stakes it holds

Nippon Shinyaku has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

SEC filer profile

How Nippon Shinyaku is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNippon Shinyaku Co Ltd2
  • CIK0001361865
  • Incorporated inJapan2
  • Fiscal year endsMarch 312
  • Business address14 Nishinosho Monguchi Cho, Kisshoin Minamiku, Kyoto, M0 000002
  • Phone81 75 321 91042
  • On EDGAR sinceMay 5, 20062
  • Filings6 in all: 3 (2), SC 13G/A (2), 4 (1), SC 13G (1)2